Renerva is developing surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.

My role as EIR at the Innovation Institute included these responsibilities:- Mentoring academic teams developing medical technologies and therapies - Guiding teams towards fundamental derisking activities- Bridging academic, business, and investing communities to create new business opportunities leveraging personal professional network- Performing due diligence on commercial opportunities based on the university technology portfolio- Scouting for technologies with high commercialization potential within the university environment

A local-based, mobile B2B (initial use case) and B2C (extended market) marketplace for used household goods of low value. The app aimed at using prescriptive analytics algorithms and other strategies to speed up the listing of the item and the overall sale cycle, dramatically reducing the efforts required to complete a sale transaction and the exchange of goods among businesses dealing with such items in bulk, between one of such businesses and users, and just among users. www.venndoo.com

Company co-founder. Co-inventor of core technology. Oversight of technology and product development, optimization, innovation, and experimental design. Key contributor to corporate portfolio of intellectual property. Coordination of technical consultants and scientific advisory board.

Management and care of patients supported by ventricular assist devices and intra aortic balloon pumps (i.e., Thoratec, Ventracor, Abiomed, Berlin Heart, Tamdem Heart, Novacor, Heartmate, Jarvik, Centrimag, Toyobo, and Arrow IABP).

Incubation and validation of a patent-pending technology involving a conformal deposition of biodegradable polymer onto veins used for coronary artery bypass grafting. Coordination of preclinical, large-animal studies.

Dissertation:”Development of a Stem Cells-Based Tissue Engineered Vascular Graft”. Multidisciplinary project involving development of cell seeding technologies, polymeric scaffolds, bioreactors, in vitro and in vivo studies in small and large animal models, and coordination of several professionals toward the creation of a clinically viable vascular substitute.

Patient-Specific 3D reconstruction of human blood vessels from angio-MRI and -CT angiography, and relative CFD analysis of flow patterns as a diagnostic procedure for assessing and predicting vascular disease.